Viewing Study NCT00079560


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-29 @ 1:56 AM
Study NCT ID: NCT00079560
Status: COMPLETED
Last Update Posted: 2017-01-11
First Post: 2004-03-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS
Sponsor: National Institute on Drug Abuse (NIDA)
Organization:

Study Overview

Official Title: THC and Marijuana--Effects in Individuals With HIV/AIDS
Status: COMPLETED
Status Verified Date: 2008-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: True
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Smoked marijuana (MJ) and dronabinol (also known as THC or by the trade name Marinol) are used to increase appetite, food intake, and weight in patients with HIV who experience unintended weight loss. This study will compare the effects of MJ and Marinol use in marijuana smokers who are HIV infected.
Detailed Description: Little is known about the efficacy and tolerability of oral THC versus smoked MJ in a clinically relevant population. Additionally, it is not clear how THC's effects vary as a function of the duration of treatment or the patient's current patterns of smoked MJ use. This study directly compares 3 doses of smoked marijuana and 3 doses of Marinol across a range of behavioral measures in HIV infected marijuana smokers.

Outcome measures will include analysis of food intake, body composition, mood, physical symptoms (e.g., nausea, stomach pain), psychomotor task performance, and sleep.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: